Nabisco Biscuit Company — AVOCADO, CILANTRO & LIME FLAVOR CRACKERS, AVOCADO, CILANTRO & LIME
by Nabisco Biscuit CompanyMRT 176 Panel Triggers Identified
Clinical Product Assessment
MRT 176 Panel Safety Assessment
Clinical Narrative
This product contains 3 MRT-tested substances: Avocado, Coriander/Cilantro, and Lime. Based on the 176-panel criteria, any product containing three or more triggers is classified as High Risk. This product is generally excluded from the Elimination (Phase 1) and Reintroduction (Phase 2) phases of the LEAP protocol. Furthermore, as a commercial cracker product, it is highly likely to contain unlisted MRT-tested starches (such as Rice, Wheat, or Corn) and oils (such as Safflower or Sunflower) which would further increase the trigger count.
Flagged Ingredient Mapping
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| AVOCADO | Avocado | DIRECT_MATCH |
| CILANTRO | Coriander/Cilantro | DIRECT_MATCH |
| LIME | Lime | DIRECT_MATCH |
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
What This Means For Your Diet
With 3 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 3 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
Full Ingredient List
AVOCADO, CILANTRO, LIME
More from Nabisco Biscuit Company
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners